Back to search results

Testing Recovery Community Centers for Opioid Use Disorder

This study is testing how well Recovery Community Centers (RCCs) help people managing Opioid Use Disorder (OUD) with medication (MOUD). RCCs are places in the community that offer support and connect people to resources. Researchers want to see if connecting people to these centers leads to better recovery compared to just getting information about different recovery activities. You can join if you are 18 or older, use MOUD, and get your MOUD from a clinic near an RCC that serves a Black community. This is a pilot study to help plan a larger trial and understand if RCCs can improve recovery outcomes. The study aims to enroll 128 participants, but its current status is unclear.

Study design
This is a pilot randomized clinical trial comparing two groups: one linked to Recovery Community Centers and another receiving enhanced usual treatment. It plans to enroll 128 participants.
What's involved
Participants linked to RCCs will be asked to visit their local RCC at least twice and write about their experiences. The study will also involve completing follow-up assessments.
Compensation
Not stated in the trial record.
Follow-up
The study will assess recovery outcomes over time, but specific follow-up durations are not detailed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07010978

Towards Testing the Effectiveness of Recovery Community Centers (RCCs)

Recruiting
NAAges 18+InterventionalHealth services
Massachusetts General Hospital
~128 participants
Updated 2025-09-26 on ClinicalTrials.gov
What's tested:Recovery Community Center ParticipationEnhance Treatment as Usual

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment Rate
Measured over Baseline

Conditions

Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Bettina Hoeppner, Ph.D., M.S. · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Bettina Hoeppner, Ph.D., M.S.
[email protected]
617-643-1988
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18+ years of age
Uses MOUD (at enrollment; participants may stop using MOUD subsequently) to treat OUD
Receives MOUD from a clinic/pharmacy located within 15 miles of an RCC vetted by our study team, which serves a Black community (i.e., defined as being located in a ZIP code where ≥27% of the residents are Black, as per US Census)
Is willing and able to engage in study procedures (i.e., online surveys, timeline follow back interview)
Is willing to be randomized

What this trial measures

  • Recruitment RateBaseline

    The recruitment rate will be estimated from the number of study participants enrolled per month; this information will be used for planning a subsequent R01, in line with the goals of the R34 mechanism used to fund this study. The recruitment rate will be reported as mean with standard deviation (based on monthly observations) and will be reported descriptively.